OptiChroniX is an American-Swiss Digital Therapeutics company dedicated to improve Brain Health for Millions.We support a healthy brain by focussing on modifiable factors in ones lifestyle and current health status as early as people in their mid forties.OptiChroniX develops a prescribed digital therapeutic (pDTX), a digital solution at the intersection of biomedical, behavioural, computing and engineering research, deployed on smartphones to personalize, track and improve a patient’s health  by collecting data from other wearables and nearables. The informed choices offered aim to provide tailored coaching in order to improve health literacy and medication adherence, and to positively impact modifiable factors primarily responsible for the cognitive decline in patients affected by Alzheimer’s disease and associated co-morbidities.